A phase I dose escalation multi-centre study of crizotinib (MET inhibitor) combined with binimetinib (MEK inhibitor) in patients with advanced solid tumours

Richard Wilson; P. Hari Dass; Sandra Van Schaeybroeck; Elena Elez; A Quinton; R. Jones; Jennifer Houlden; Linda Collins; C Roberts; Sharon Love; Mark Lawler; Federica Di Nicolantonio; Margaret Grayson; alberto Bardelli; Pierre Laurent=puig; Tim Maughan; Josef Tabernero; Marc Peeters; Mark Middleton; Christian Rolfo

A phase I dose escalation multi-centre study of crizotinib (MET inhibitor) combined with binimetinib (MEK inhibitor) in patients with advanced solid tumours

Richard Wilson, P. Hari Dass, Sandra Van Schaeybroeck, Elena Elez, A Quinton, R. Jones, Jennifer Houlden, Linda Collins, C Roberts, Sharon Love, Mark Lawler, Federica Di Nicolantonio, Margaret Grayson, alberto Bardelli, Pierre Laurent=puig, Tim Maughan, Josef Tabernero, Marc Peeters, Mark Middleton, Christian Rolfo

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	e140-e141
Journal	European Journal of Cancer
Volume	103
Issue number	Suppl 1
Publication status	Published - Nov 2018

Access to Document

https://www.sciencedirect.com/journal/european-journal-of-cancer/vol/103/suppl/S1Licence: Unspecified

Cite this

Wilson, R., Dass, P. H., Van Schaeybroeck, S., Elez, E., Quinton, A., Jones, R., Houlden, J., Collins, L., Roberts, C., Love, S., Lawler, M., Di Nicolantonio, F., Grayson, M., Bardelli, A., Laurent=puig, P., Maughan, T., Tabernero, J., Peeters, M., Middleton, M., & Rolfo, C. (2018). A phase I dose escalation multi-centre study of crizotinib (MET inhibitor) combined with binimetinib (MEK inhibitor) in patients with advanced solid tumours. European Journal of Cancer, 103(Suppl 1), e140-e141. https://www.sciencedirect.com/journal/european-journal-of-cancer/vol/103/suppl/S1

@article{149f2ca3f6a64f5dac4e04b7acc6616b,

title = "A phase I dose escalation multi-centre study of crizotinib (MET inhibitor) combined with binimetinib (MEK inhibitor) in patients with advanced solid tumours",

author = "Richard Wilson and Dass, {P. Hari} and {Van Schaeybroeck}, Sandra and Elena Elez and A Quinton and R. Jones and Jennifer Houlden and Linda Collins and C Roberts and Sharon Love and Mark Lawler and {Di Nicolantonio}, Federica and Margaret Grayson and alberto Bardelli and Pierre Laurent=puig and Tim Maughan and Josef Tabernero and Marc Peeters and Mark Middleton and Christian Rolfo",

year = "2018",

month = nov,

language = "English",

volume = "103",

pages = "e140--e141",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

number = "Suppl 1",

}

Wilson, R, Dass, PH, Van Schaeybroeck, S, Elez, E, Quinton, A, Jones, R, Houlden, J, Collins, L, Roberts, C, Love, S, Lawler, M, Di Nicolantonio, F, Grayson, M, Bardelli, A, Laurent=puig, P, Maughan, T, Tabernero, J, Peeters, M, Middleton, M & Rolfo, C 2018, 'A phase I dose escalation multi-centre study of crizotinib (MET inhibitor) combined with binimetinib (MEK inhibitor) in patients with advanced solid tumours', European Journal of Cancer, vol. 103, no. Suppl 1, pp. e140-e141. <https://www.sciencedirect.com/journal/european-journal-of-cancer/vol/103/suppl/S1>

A phase I dose escalation multi-centre study of crizotinib (MET inhibitor) combined with binimetinib (MEK inhibitor) in patients with advanced solid tumours. / Wilson, Richard; Dass, P. Hari; Van Schaeybroeck, Sandra et al.
In: European Journal of Cancer, Vol. 103, No. Suppl 1, 11.2018, p. e140-e141.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - A phase I dose escalation multi-centre study of crizotinib (MET inhibitor) combined with binimetinib (MEK inhibitor) in patients with advanced solid tumours

AU - Wilson, Richard

AU - Dass, P. Hari

AU - Van Schaeybroeck, Sandra

AU - Elez, Elena

AU - Quinton, A

AU - Jones, R.

AU - Houlden, Jennifer

AU - Collins, Linda

AU - Roberts, C

AU - Love, Sharon

AU - Lawler, Mark

AU - Di Nicolantonio, Federica

AU - Grayson, Margaret

AU - Bardelli, alberto

AU - Laurent=puig, Pierre

AU - Maughan, Tim

AU - Tabernero, Josef

AU - Peeters, Marc

AU - Middleton, Mark

AU - Rolfo, Christian

PY - 2018/11

Y1 - 2018/11

M3 - Meeting abstract

SN - 0959-8049

VL - 103

SP - e140-e141

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - Suppl 1

ER -